吉利德科学宣布与Pepfar建立合作伙伴关系,将向主要位于低收入和中低收入国家的最多200万人提供每年两次的Lenacapavir药物,用于HIV预防治疗。
吉利德科学宣布与Pepfar建立合作伙伴关系,将向主要位于低收入和中低收入国家的最多200万人提供每年两次的Lenacapavir药物,用于HIV预防治疗。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.